GSK Drops Agenerase 150 mg Capsules
This article was originally published in The Pink Sheet Daily
Executive Summary
Discontinuation stems from low clinical demand, the company says. The protease inhibitor will continue to be available in 50 mg capsules and 15 mg/mL oral solution.